Vertex Pharmaceuticals Incorporated
Daniel J. Brennan (Director) reports VRTX insider transactions
AI-generated summary
Director Daniel J. Brennan received 795 shares of Common Stock as a grant valued at $400,258.65 on October 20, 2026. Following this transaction, the insider directly held 795 shares.
Key facts
- Insider
- Daniel J. Brennan · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | A · grantFootnotes F1 | +795 | $503.47 | $400,258.65 | 795 | Direct |
Footnotes
- F1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
More VRTX filings
- 3
Filed Oct 22, 2026
- 8-K
Filed Oct 20, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Sep 10, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.